Organizer
Phenomenex
Phenomenex
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety to environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.
Tags
HPLC
Consumables
Columns
LC/MS
LC/HRMS
LC/MS/MS
LinkedIn Logo

Method Development and Optimization of Native RPLC-HRMS Characterization of ADCs using Biozen Native RP Columns

RECORD | Already taken place We, 29.10.2025
Learn how to develop and optimize native RPLC-HRMS methods for ADC characterization. Explore DAR analysis, isomer separation, and MS-friendly workflows using Biozen Native RP columns.
Go to the webinar
Phenomenex: Method Development and Optimization of Native RPLC-HRMS Characterization of ADCs using Biozen Native RP Columns
Phenomenex: Method Development and Optimization of Native RPLC-HRMS Characterization of ADCs using Biozen Native RP Columns
During this presention, we will review the following:
  • An RPLC-HRMS method development approach for rapid, comprehensive DAR analysis, including positional isomers, under native conditions.
  • Sorbent polarity and hydrophobicity effects on retention and selectivity of individual DAR species.
  • Optimized chromatographic separation and MS identification of all DAR species, including positional isomers, of several ADCs.

Key Learning Points

  • Learn about method development approach for native RPLC-HRMS of ADCs using Biozen Native RP columns.
  • Take a deep dive into method optimization strategies.
  • Examine online HRMS identification of individual DAR species.

Who Should Attend

  • Characterization and In-process scientists needing to develop robust, MS friendly methods to characterize and identify individual DAR species, including positional isomers, and average drug to antibody ratios (DAR) of antibody drug conjugates (ADCs).

Speaker: Carl Sanchez (Principal Scientific Advisor, Phenomenex)

Carl Sanchez is a Principal Scientific Advisor in Phenomenex R&D where he provides subject matter expertise and advanced technical problem-solving support to Phenomenex businesses and customers. Additionally, Carl is actively involved in new product development projects spanning HPLC, sample preparation and GC. Carl has authored multiple papers on HPLC in peer reviewed journals as well as given over 100 lectures at scientific conferences worldwide. Carl’s current research interests include LC-MS characterization of biotherapeutics.

Phenomenex
LinkedIn Logo
 

Related content

Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System

Posters
| 2026 | Agilent Technologies (ASMS)
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma

Increased sensitivity for low-input label-free proteomics using the Orbitrap Astral MS and μPAC Neo Plus Columns

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
LC/HRMS, LC/Orbitrap, LC/MS, LC/MS/MS
Manufacturer
Thermo Fisher Scientific
Industries
Proteomics

Mind the pressure in preparative up-scaling – effects of particle size and solvent composition on back pressure

Technical notes
| 2026 | KNAUER
Instrumentation
HPLC, Consumables, LC columns
Manufacturer
KNAUER
Industries
Other

Two-Step Matrix Deposition for Improved MS Imaging Resolution

Posters
| 2026 | Shimadzu (ASMS)
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, MALDI, MS Imaging
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

Smart Monitoring & Optimization Solutions for SMB Processes: In-Line and Off-Line Tools for SMB Systems

Technical notes
| 2026 | KNAUER
Instrumentation
HPLC
Manufacturer
KNAUER
Industries
Pharma & Biopharma
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike